Build Your Comparison

Side-by-side financial analysis
VVX logo
VVX
DLB logo
DLB
JPM logo
JPM
BAC logo
BAC
LDOS logo
LDOS
Try popular comparisons:

Stock Comparison

VVX vs DLB vs JPM vs BAC vs LDOS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
VVX
V2X, Inc.

Aerospace & Defense

IndustrialsNYSE • US
Market Cap$2.84B
5Y Perf.+84.8%
DLB
Dolby Laboratories, Inc.

Information Technology Services

TechnologyNYSE • US
Market Cap$5.02B
5Y Perf.-20.3%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+241.0%
BAC
Bank of America Corporation

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$422.78B
5Y Perf.+135.9%
LDOS
Leidos Holdings, Inc.

Information Technology Services

TechnologyNYSE • US
Market Cap$15.37B
5Y Perf.+30.4%

VVX vs DLB vs JPM vs BAC vs LDOS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
VVX logoVVX
DLB logoDLB
JPM logoJPM
BAC logoBAC
LDOS logoLDOS
IndustryAerospace & DefenseInformation Technology ServicesBanks - DiversifiedBanks - DiversifiedInformation Technology Services
Market Cap$2.84B$5.02B$896.00B$422.78B$15.37B
Revenue (TTM)$4.72B$1.34B$280.33B$191.57B$17.48B
Net Income (TTM)$89M$241M$57.05B$30.51B$1.36B
Gross Margin8.5%87.9%60.0%56.1%17.3%
Operating Margin4.3%18.8%25.9%19.7%11.6%
Forward P/E14.9x12.2x14.4x12.6x10.3x
Total Debt$1.17B$39M$942.38B$365.90B$5.93B
Cash & Equiv.$369M$702M$343.34B$231.84B$1.20B

VVX vs DLB vs JPM vs BAC vs LDOSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

VVX
DLB
JPM
BAC
LDOS
StockJun 20Jun 26Return
V2X, Inc. (VVX)100184.8+84.8%
Dolby Laboratories,… (DLB)10079.7-20.3%
JPMorgan Chase & Co. (JPM)100341.0+241.0%
Bank of America Cor… (BAC)100235.9+135.9%
Leidos Holdings, In… (LDOS)100130.4+30.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: VVX vs DLB vs JPM vs BAC vs LDOS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LDOS leads in 3 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and capital preservation and lower volatility. Dolby Laboratories, Inc. is the stronger pick specifically for growth and revenue expansion and dividend income and shareholder returns. VVX and JPM also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇LDOS emerged as the overall leader. Track its performance:
VVX
V2X, Inc.
The Growth Play

VVX ranks third and is worth considering specifically for growth exposure.

  • Rev growth 3.7%, EPS growth 126.9%, 3Y rev CAGR 15.7%
  • +100.7% vs DLB's -28.3%
Best for: growth exposure
DLB
Dolby Laboratories, Inc.
The Income Pick

DLB is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.

  • Dividend streak 12 yrs, beta 0.79, yield 2.5%
  • Lower volatility, beta 0.79, Low D/E 1.5%, current ratio 3.17x
  • Beta 0.79, yield 2.5%, current ratio 3.17x
  • 5.9% revenue growth vs BAC's -0.5%
Best for: income & stability and sleep-well-at-night
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM is the clearest fit if your priority is long-term compounding and bank quality.

  • 465.8% 10Y total return vs BAC's 368.2%
  • NIM 2.2% vs BAC's 1.8%
  • 20.4% margin vs VVX's 1.9%
Best for: long-term compounding and bank quality
BAC
Bank of America Corporation
The Financial Play

Among these 5 stocks, BAC doesn't own a clear edge in any measured category.

Best for: financial services exposure
LDOS
Leidos Holdings, Inc.
The Value Pick

LDOS carries the broadest edge in this set and is the clearest fit for valuation efficiency.

  • PEG 0.50 vs DLB's 3.94
  • Lower P/E (10.3x vs 12.2x), PEG 0.50 vs 3.94
  • Beta 0.38 vs JPM's 0.94, lower leverage
  • 9.4% ROA vs BAC's 0.9%, ROIC 17.1% vs 3.5%
Best for: valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthDLB logoDLB5.9% revenue growth vs BAC's -0.5%
ValueLDOS logoLDOSLower P/E (10.3x vs 12.2x), PEG 0.50 vs 3.94
Quality / MarginsJPM logoJPM20.4% margin vs VVX's 1.9%
Stability / SafetyLDOS logoLDOSBeta 0.38 vs JPM's 0.94, lower leverage
DividendsDLB logoDLB2.5% yield, 12-year raise streak, vs JPM's 1.9%, (1 stock pays no dividend)
Momentum (1Y)VVX logoVVX+100.7% vs DLB's -28.3%
Efficiency (ROA)LDOS logoLDOS9.4% ROA vs BAC's 0.9%, ROIC 17.1% vs 3.5%

VVX vs DLB vs JPM vs BAC vs LDOS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Defense Stocks Theme

These companies are key players in the Defense Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
VVXV2X, Inc.
FY 2025
Fixed-Price Contract
92.7%$1.6B
Time-and-Materials Contract
7.3%$126M
DLBDolby Laboratories, Inc.
FY 2025
Licensing, Brodcast Revenue
31.8%$428M
Licensing, Mobile Revenue
19.9%$269M
Licensing, Other Revenue
18.4%$248M
Licensing, PC Revenue
11.3%$152M
Licensing, CE Revenue
11.2%$151M
Products And Services
7.5%$101M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
BACBank of America Corporation
FY 2024
Loans and Leases
32.2%$62.0B
other interest income
14.7%$28.3B
Debt securities
13.5%$26.0B
Federal funds sold and securities borrowed or purchased under agreements to resell
10.3%$19.9B
Investment And Brokerage Services
9.2%$17.8B
Market making and similar activities
6.7%$13.0B
Trading account assets
5.4%$10.4B
Other (4)
7.8%$15.1B
LDOSLeidos Holdings, Inc.
FY 2025
National Security Solutions
57.7%$9.9B
Civil Segment
29.5%$5.1B
Defense Solution Segment
12.7%$2.2B

VVX vs DLB vs JPM vs BAC vs LDOS — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGBAC

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 3 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 209.4x DLB's $1.3B. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to VVX's 1.9%. On growth, VVX holds the edge at +23.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricVVX logoVVXV2X, Inc.DLB logoDLBDolby Laboratorie…JPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…LDOS logoLDOSLeidos Holdings, …
RevenueTrailing 12 months$4.7B$1.3B$280.3B$191.6B$17.5B
EBITDAEarnings before interest/tax$289M$352M$81.4B$40.0B$2.2B
Net IncomeAfter-tax profit$89M$241M$57.0B$30.5B$1.4B
Free Cash FlowCash after capex$136M$380M$100.9B$12.6B$1.7B
Gross MarginGross profit ÷ Revenue+8.5%+87.9%+60.0%+56.1%+17.3%
Operating MarginEBIT ÷ Revenue+4.3%+18.8%+25.9%+19.7%+11.6%
Net MarginNet income ÷ Revenue+1.9%+18.0%+20.4%+15.9%+7.8%
FCF MarginFCF ÷ Revenue+2.9%+28.4%+36.0%+6.6%+9.6%
Rev. Growth (YoY)Latest quarter vs prior year+23.4%-2.9%+3.7%
EPS Growth (YoY)Latest quarter vs prior year+140.0%-21.4%+16.0%+18.3%-7.6%
JPM leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

LDOS leads this category, winning 4 of 7 comparable metrics.

At 11.0x trailing earnings, LDOS trades at a 70% valuation discount to VVX's 37.1x P/E. Adjusting for growth (PEG ratio), LDOS offers better value at 0.53x vs DLB's 6.48x — a lower PEG means you pay less per unit of expected earnings growth.

MetricVVX logoVVXV2X, Inc.DLB logoDLBDolby Laboratorie…JPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…LDOS logoLDOSLeidos Holdings, …
Market CapShares × price$2.8B$5.0B$896.0B$422.8B$15.4B
Enterprise ValueMkt cap + debt − cash$3.6B$4.4B$1.50T$556.8B$20.1B
Trailing P/EPrice ÷ TTM EPS37.07x20.05x16.00x14.66x10.98x
Forward P/EPrice ÷ next-FY EPS est.14.91x12.19x14.40x12.56x10.32x
PEG RatioP/E ÷ EPS growth rate6.48x0.90x0.95x0.53x
EV / EBITDAEnterprise value multiple11.88x11.98x18.36x13.92x8.35x
Price / SalesMarket cap ÷ Revenue0.63x3.72x3.20x2.21x0.89x
Price / BookPrice ÷ Book value/share2.66x1.95x2.47x1.39x3.26x
Price / FCFMarket cap ÷ FCF16.72x11.66x8.88x33.52x9.46x
LDOS leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

LDOS leads this category, winning 5 of 9 comparable metrics.

LDOS delivers a 27.1% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $8 for VVX. DLB carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), VVX scores 8/9 vs JPM's 5/9, reflecting strong financial health.

MetricVVX logoVVXV2X, Inc.DLB logoDLBDolby Laboratorie…JPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…LDOS logoLDOSLeidos Holdings, …
ROE (TTM)Return on equity+8.2%+9.2%+15.9%+10.1%+27.1%
ROA (TTM)Return on assets+2.7%+7.5%+1.3%+0.9%+9.4%
ROICReturn on invested capital+7.7%+10.1%+4.5%+3.5%+17.1%
ROCEReturn on capital employed+8.4%+9.6%+8.9%+4.5%+21.0%
Piotroski ScoreFundamental quality 0–986578
Debt / EquityFinancial leverage1.08x0.01x2.60x1.21x1.19x
Net DebtTotal debt minus cash$801M-$663M$599.0B$134.1B$4.7B
Cash & Equiv.Liquid assets$369M$702M$343.3B$231.8B$1.2B
Total DebtShort + long-term debt$1.2B$39M$942.4B$365.9B$5.9B
Interest CoverageEBIT ÷ Interest expense3.50x65.71x0.74x0.48x9.91x
LDOS leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $5,794 for DLB. Over the past 12 months, VVX leads with a +100.7% total return vs DLB's -28.3%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs DLB's -12.5% — a key indicator of consistent wealth creation.

MetricVVX logoVVXV2X, Inc.DLB logoDLBDolby Laboratorie…JPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…LDOS logoLDOSLeidos Holdings, …
YTD ReturnYear-to-date+63.4%-16.2%-0.5%+1.1%-33.2%
1-Year ReturnPast 12 months+100.7%-28.3%+21.8%+28.1%-16.3%
3-Year ReturnCumulative with dividends+96.6%-33.0%+138.2%+103.0%+51.0%
5-Year ReturnCumulative with dividends+67.2%-42.1%+118.2%+47.1%+21.6%
10-Year ReturnCumulative with dividends+251.6%+32.2%+465.8%+368.2%+212.3%
CAGR (3Y)Annualised 3-year return+25.3%-12.5%+33.6%+26.6%+14.7%
JPM leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — VVX and LDOS each lead in 1 of 2 comparable metrics.

LDOS is the less volatile stock with a 0.38 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VVX currently trades 99.1% from its 52-week high vs LDOS's 59.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricVVX logoVVXV2X, Inc.DLB logoDLBDolby Laboratorie…JPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…LDOS logoLDOSLeidos Holdings, …
Beta (5Y)Sensitivity to S&P 5000.85x0.79x0.94x0.86x0.38x
52-Week HighHighest price in past year$91.64$77.00$337.25$57.55$205.77
52-Week LowLowest price in past year$43.80$51.78$262.71$43.66$121.20
% of 52W HighCurrent price vs 52-week peak+99.1%+68.2%+95.1%+97.3%+59.4%
RSI (14)Momentum oscillator 0–10081.833.159.168.332.4
Avg Volume (50D)Average daily shares traded471K675K7.0M31.7M1.0M
Evenly matched — VVX and LDOS each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — DLB and JPM each lead in 1 of 2 comparable metrics.

Analyst consensus: VVX as "Buy", DLB as "Buy", JPM as "Buy", BAC as "Buy", LDOS as "Buy". Consensus price targets imply 72.0% upside for DLB (target: $90) vs -13.4% for VVX (target: $79). For income investors, DLB offers the higher dividend yield at 2.47% vs LDOS's 1.30%.

MetricVVX logoVVXV2X, Inc.DLB logoDLBDolby Laboratorie…JPM logoJPMJPMorgan Chase & …BAC logoBACBank of America C…LDOS logoLDOSLeidos Holdings, …
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$78.60$90.33$339.75$61.13$187.33
# AnalystsCovering analysts1917615427
Dividend YieldAnnual dividend ÷ price+2.5%+1.9%+2.3%+1.3%
Dividend StreakConsecutive years of raises1215127
Dividend / ShareAnnual DPS$1.30$5.95$1.27$1.59
Buyback YieldShare repurchases ÷ mkt cap+1.1%+3.2%+3.9%+5.1%+6.1%
Evenly matched — DLB and JPM each lead in 1 of 2 comparable metrics.
Key Takeaway

JPM leads in 2 of 6 categories (Income & Cash Flow, Total Returns). LDOS leads in 2 (Valuation Metrics, Profitability & Efficiency). 2 tied.

Best OverallJPMorgan Chase & Co. (JPM)Leads 2 of 6 categories
Loading custom metrics...

VVX vs DLB vs JPM vs BAC vs LDOS: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is VVX or DLB or JPM or BAC or LDOS a better buy right now?

For growth investors, Dolby Laboratories, Inc.

(DLB) is the stronger pick with 5. 9% revenue growth year-over-year, versus -0. 5% for Bank of America Corporation (BAC). Leidos Holdings, Inc. (LDOS) offers the better valuation at 11. 0x trailing P/E (10. 3x forward), making it the more compelling value choice. Analysts rate V2X, Inc. (VVX) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — VVX or DLB or JPM or BAC or LDOS?

On trailing P/E, Leidos Holdings, Inc.

(LDOS) is the cheapest at 11. 0x versus V2X, Inc. at 37. 1x. On forward P/E, Leidos Holdings, Inc. is actually cheaper at 10. 3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Leidos Holdings, Inc. wins at 0. 50x versus Dolby Laboratories, Inc. 's 3. 94x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — VVX or DLB or JPM or BAC or LDOS?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to -42. 1% for Dolby Laboratories, Inc. (DLB). Over 10 years, the gap is even starker: JPM returned +465. 8% versus DLB's +32. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — VVX or DLB or JPM or BAC or LDOS?

By beta (market sensitivity over 5 years), Leidos Holdings, Inc.

(LDOS) is the lower-risk stock at 0. 38β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 148% more volatile than LDOS relative to the S&P 500. On balance sheet safety, Dolby Laboratories, Inc. (DLB) carries a lower debt/equity ratio of 1% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — VVX or DLB or JPM or BAC or LDOS?

By revenue growth (latest reported year), Dolby Laboratories, Inc.

(DLB) is pulling ahead at 5. 9% versus -0. 5% for Bank of America Corporation (BAC). On earnings-per-share growth, the picture is similar: V2X, Inc. grew EPS 126. 9% year-over-year, compared to -2. 6% for Dolby Laboratories, Inc.. Over a 3-year CAGR, VVX leads at 15. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — VVX or DLB or JPM or BAC or LDOS?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus 1. 7% for V2X, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 4. 3% for VVX. At the gross margin level — before operating expenses — DLB leads at 88. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is VVX or DLB or JPM or BAC or LDOS more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Leidos Holdings, Inc. (LDOS) is the more undervalued stock at a PEG of 0. 50x versus Dolby Laboratories, Inc. 's 3. 94x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Leidos Holdings, Inc. (LDOS) trades at 10. 3x forward P/E versus 14. 9x for V2X, Inc. — 4. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DLB: 72. 0% to $90. 33.

08

Which pays a better dividend — VVX or DLB or JPM or BAC or LDOS?

In this comparison, DLB (2.

5% yield), BAC (2. 3% yield), JPM (1. 9% yield), LDOS (1. 3% yield) pay a dividend. VVX does not pay a meaningful dividend and should not be held primarily for income.

09

Is VVX or DLB or JPM or BAC or LDOS better for a retirement portfolio?

For long-horizon retirement investors, Leidos Holdings, Inc.

(LDOS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 38), 1. 3% yield, +212. 3% 10Y return). Both have compounded well over 10 years (LDOS: +212. 3%, VVX: +251. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between VVX and DLB and JPM and BAC and LDOS?

These companies operate in different sectors (VVX (Industrials) and DLB (Technology) and JPM (Financial Services) and BAC (Financial Services) and LDOS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: VVX is a small-cap quality compounder stock; DLB is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock; LDOS is a mid-cap deep-value stock. DLB, JPM, BAC, LDOS pay a dividend while VVX does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.